Fesoterodine

In the US, Fesoterodine (fesoterodine systemic) is a member of the drug class urinary antispasmodics and is used to treat Overactive Bladder and Urinary Incontinence.

US matches:

• Fesoterodine


• Fesoterodine Fumarate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G04BD11

CAS registry number (Chemical Abstracts Service)

0286930-02-7

Chemical Formula

C26-H37-N-O3

Molecular Weight

411

Therapeutic Category

Muscarin receptor antagonist

Chemical Names

2-[(R)-Isobuttersäure-3-(diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenylester (IUPAC)

2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenylisobutyrate (WHO)

Foreign Names

• Fesoterodinum (Latin)
• Fesoterodin (German)
• Fésotérodine (French)
• Fesoterodina (Spanish)

Generic Names

• SPM-907 (IS)
• Fesoterodine fumarate (OS: USAN)
• SPM 8272 (IS: SchwarzPharma)
• UNII-EOS72165S7 (IS)

Brand Names

• Toviaz
  Pfizer, Ireland; Pfizer, Belgium; Pfizer, Switzerland; Pfizer, Germany; Pfizer, Denmark; Pfizer, United Kingdom; Pfizer, Netherlands; Pfizer, Norway; Pfizer, Sweden; Pfizer, Slovakia; Pfizer, United States

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.